1,3-dipropyl-8-cyclopentylxanthine has been researched along with furosemide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, A; Karasawa, A; Kawakita, T; Kubo, K; Mizumoto, H; Nonaka, H; Shimada, J; Suzuki, F | 1 |
Ishii, A; Karasawa, A; Kubo, K; Mizumoto, H; Nonaka, H; Ohno, T; Shimada, J; Suzuki, F | 1 |
Cohen, FE; Legname, G; May, BC; Prusiner, SB; Sherrill, J; Wallace, AC; Witkop, J; Zorn, JA | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Herzer, WA; Jackson, EK; Kost, CK; Mi, Z; Rominski, BR | 1 |
Cook, AK; Evans, RJ; Imig, JD; Inscho, EW; Vial, C | 1 |
Hill, CE; Inoue, T; Kanno, Y; Okada, H; Suzuki, H; Takenaka, T | 1 |
8 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and furosemide
Article | Year |
---|---|
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Cations, Monovalent; Diuretics; Male; Potassium; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sodium; Structure-Activity Relationship; Xanthines | 1992 |
8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities.
Topics: Animals; Diuretics; Indicators and Reagents; Kidney; Kidney Function Tests; Kinetics; Male; Molecular Structure; Rats; Rats, Inbred Strains; Receptors, Purinergic; Structure-Activity Relationship; Xanthines | 1991 |
Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Combinatorial Chemistry Techniques; Membranes, Artificial; Mice; Models, Molecular; Nitriles; Permeability; PrPSc Proteins; Solubility; Structure-Activity Relationship | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Diuretic response to adenosine A(1) receptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins.
Topics: Animals; Blood Pressure; Diuresis; Drug Interactions; Furosemide; GTP-Binding Proteins; Hypertension; Male; Natriuresis; Pertussis Toxin; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Purinergic P1; Virulence Factors, Bordetella; Xanthines | 2000 |
Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.
Topics: Adenosine Triphosphate; Animals; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gene Deletion; Kidney; Male; Mice; Mice, Knockout; Microcirculation; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Renal Circulation; Suramin; Time Factors; Xanthines | 2003 |
Connexins 37 and 40 transduce purinergic signals mediating renal autoregulation.
Topics: Animals; Connexins; Furosemide; Gap Junction alpha-4 Protein; Gap Junction alpha-5 Protein; Glomerular Filtration Rate; Homeostasis; Kidney; Male; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic; Receptors, Purinergic P1; Regional Blood Flow; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors; Xanthines | 2008 |